1.
Braz. j. infect. dis
; 19(2): 226-227, Mar-Apr/2015.
Article
in English
| LILACS
| ID: lil-746506
Subject(s)
Humans , HIV Infections/complications , Hepacivirus/genetics , Hepatitis C/drug therapy , Oligopeptides/therapeutic use , Protease Inhibitors/therapeutic use , Coinfection , Genotype , Hepatitis C/complications , Hepatitis C/virology , Oligopeptides/adverse effects , Protease Inhibitors/adverse effects , Treatment Outcome
2.
Braz J Infect Dis
; 19(2): 226-7, 2015.
Article
in English
| MEDLINE
| ID: mdl-25528578